» Articles » PMID: 32518104

Restarting Gastrointestinal Endoscopy in the Deceleration and Early Recovery Phases of COVID-19 Pandemic: Guidance from the British Society of Gastroenterology

Overview
Journal Clin Med (Lond)
Specialty General Medicine
Date 2020 Jun 11
PMID 32518104
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Many non-emergency clinical services were suspended during COVID-19 pandemic peak. It is essential to develop a plan for restarting services following the peak. It is equally important to protect patients and staff and to use resources and personal protective equipment (PPE) efficiently. The British Society of Gastroenterology Endoscopy Committee and Quality Improvement Programme has produced guidance on how a restart can be safely delivered. Key recommendations include the following: all patients should have need for endoscopy assessed by senior clinicians and prioritised according to criteria we have outlined; once the need for endoscopy is confirmed, patients should undergo telephone screening for symptoms using systematic questionnaires; all outpatients should undergo RT-PCR testing for COVID-19 virus 1-3 days prior to endoscopy; and PPE should be determined by patient risk stratification, the nature of the procedure and the results of testing. While this guidance is tailored to endoscopy services, it could be adapted for any interventional medical discipline.

Citing Articles

The impact of the COVID-19 pandemic on clinical practices related to colorectal cancer and colonoscopy in South Korea: a nationwide population-based study.

Yoon J, Lee M, Kwak M, Cha J Intest Res. 2024; 23(1):85-95.

PMID: 39610265 PMC: 11834355. DOI: 10.5217/ir.2024.00066.


'I Do It All Alone': The Burdens and Benefits of Being Diagnosed With, and Treated for, Colorectal Cancer During the Covid-19 Pandemic.

Dobson C, Deane J, Osborne B, Araujo-Soares V, Rees C, Angell L Health Expect. 2024; 27(3):e14110.

PMID: 38872460 PMC: 11176574. DOI: 10.1111/hex.14110.


Using saliva epigenetic data to develop and validate a multivariable predictor of esophageal cancer status.

Stone T, Ward V, Hogan A, Alexander Ho K, Wilson A, McBain H Epigenomics. 2024; 16(2):109-125.

PMID: 38226541 PMC: 10825730. DOI: 10.2217/epi-2023-0248.


Changes of Colorectal Cancer Diagnostics and Hospitalizations during First Wave of COVID-19 Pandemic in Lithuania.

Jurkeviciute D, Mauraviciute S, Dulskas A, Kildusiene I, Stratilatovas E, Jarmalaite S Acta Med Litu. 2023; 30(1):39-44.

PMID: 37575381 PMC: 10417012. DOI: 10.15388/Amed.2023.30.1.4.


Healthcare in England was affected by the COVID-19 pandemic across the pancreatic cancer pathway: A cohort study using OpenSAFELY-TPP.

Lemanska A, Andrews C, Fisher L, Bacon S, Frampton A, Mehrkar A Elife. 2023; 12.

PMID: 37561116 PMC: 10414967. DOI: 10.7554/eLife.85332.


References
1.
Han J, Wang Y, Zhu L, Cui Y, Li L, Zeng Z . Preventing the spread of COVID-19 in digestive endoscopy during the resuming period: meticulous execution of screening procedures. Gastrointest Endosc. 2020; 92(2):445-447. PMC: 7130750. DOI: 10.1016/j.gie.2020.03.3855. View

2.
Gralnek I, Hassan C, Beilenhoff U, Antonelli G, Ebigbo A, Pellise M . ESGE and ESGENA Position Statement on gastrointestinal endoscopy and the COVID-19 pandemic. Endoscopy. 2020; 52(6):483-490. PMC: 7295280. DOI: 10.1055/a-1155-6229. View

3.
Zang R, Gomez Castro M, McCune B, Zeng Q, Rothlauf P, Sonnek N . TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Sci Immunol. 2020; 5(47). PMC: 7285829. DOI: 10.1126/sciimmunol.abc3582. View

4.
Lui R, Wong S, Sanchez-Luna S, Pellino G, Bollipo S, Wong M . Overview of guidance for endoscopy during the coronavirus disease 2019 pandemic. J Gastroenterol Hepatol. 2020; 35(5):749-759. DOI: 10.1111/jgh.15053. View

5.
Calderwood A, Day L, Muthusamy V, Collins J, Hambrick 3rd R, Brock A . ASGE guideline for infection control during GI endoscopy. Gastrointest Endosc. 2018; 87(5):1167-1179. DOI: 10.1016/j.gie.2017.12.009. View